Update From the Dedalo Protocol: An Integrated Approach to MRD in CLL Patients Receiving Venetoclax Plus Rituximab
07:30am - 03:45pm EDT - April 1, 2023



Author(s):
Tags: Clinical Oncology

Display Label Action